What does DR. SCHRAEPEN VÉRONIQUE do?

DR. SCHRAEPEN VÉRONIQUE is a general practice in Lommel. Private Limited, started on 6 July 2018, 1 establishment.

What is the address of DR. SCHRAEPEN VÉRONIQUE?

The registered office of DR. SCHRAEPEN VÉRONIQUE is located at Lutlommel 69, 3920 Lommel.

Is DR. SCHRAEPEN VÉRONIQUE still active?

Yes. According to the CBE (17 September 2026) DR. SCHRAEPEN VÉRONIQUE is active, legal situation “Normale toestand”, started on 6 July 2018.

Is DR. SCHRAEPEN VÉRONIQUE registered on Peppol?

Yes, DR. SCHRAEPEN VÉRONIQUE is registered on the Peppol network with ID 0208:0699692771.

What is the enterprise number of DR. SCHRAEPEN VÉRONIQUE?

The enterprise number of DR. SCHRAEPEN VÉRONIQUE is BE0699692771.

When was DR. SCHRAEPEN VÉRONIQUE founded?

DR. SCHRAEPEN VÉRONIQUE was founded on 6 July 2018.

Who are the directors of DR. SCHRAEPEN VÉRONIQUE?

According to the 2025 annual accounts, the directors of DR. SCHRAEPEN VÉRONIQUE are: Véronique Schraepen.

Is DR. SCHRAEPEN VÉRONIQUE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 July 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. SCHRAEPEN VÉRONIQUE make in 2025?

DR. SCHRAEPEN VÉRONIQUE posted a profit after taxes of € 111,257 in financial year 2025.

What is the revenue of DR. SCHRAEPEN VÉRONIQUE?

As a small company, DR. SCHRAEPEN VÉRONIQUE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 130,861.

DR. SCHRAEPEN VÉRONIQUE (Private Limited) - Lommel

Dossier DR. SCHRAEPEN VÉRONIQUE, printed on 17 September 2026 from databakkes.be/en/0699692771/dr-schraepen-veronique. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. SCHRAEPEN VÉRONIQUE from Lommel, company number BE0699692771, closed financial year 2025 with a result of € 111,257 after tax. For that financial year DR. SCHRAEPEN VÉRONIQUE recorded a gross margin of € 130,861 and equity of € 18,600. Compared with financial year 2024, the result moved from € 133,714 to € 111,257. The company is profitable. The buffer shrank hard: equity is 91 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.

What it is worth Shrank hard

€ 18,600

▼ 91% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 111,257

▼ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 101,886

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 289,734 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 699

▼ 72% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18,479

▲ 49% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 144,031 Gross margin 2022: € 144,031 First fiscal year in the series	€ 136,068 Gross margin 2023: € 136,068 ▼ 6% vs 2022 (€ 144,031) Unfavourable step	€ 135,970 Gross margin 2024: € 135,970 Unchanged (€ 136,068) Unfavourable step	€ 130,861 Gross margin 2025: € 130,861 ▼ 4% vs 2024 (€ 135,970) Unfavourable step	▼ 4%
Profit after taxes	€ 105,642 Profit after taxes 2022: € 105,642 First fiscal year in the series	€ 110,925 Profit after taxes 2023: € 110,925 ▲ 5% vs 2022 (€ 105,642) Favourable step	€ 133,714 Profit after taxes 2024: € 133,714 ▲ 21% vs 2023 (€ 110,925) Favourable step	€ 111,257 Profit after taxes 2025: € 111,257 ▼ 17% vs 2024 (€ 133,714) Unfavourable step	▼ 17%
Equity	€ 457,437 Equity 2022: € 457,437 First fiscal year in the series	€ 118,363 Equity 2023: € 118,363 ▼ 74% vs 2022 (€ 457,437) Unfavourable step	€ 197,077 Equity 2024: € 197,077 ▲ 67% vs 2023 (€ 118,363) Favourable step	€ 18,600 Equity 2025: € 18,600 ▼ 91% vs 2024 (€ 197,077) Unfavourable step	▼ 91%
Total debts	€ 22,743 Total debts 2022: € 22,743 First fiscal year in the series	€ 65,575 Total debts 2023: € 65,575 ▲ 188% vs 2022 (€ 22,743) Unfavourable step	€ 95,511 Total debts 2024: € 95,511 ▲ 46% vs 2023 (€ 65,575) Unfavourable step	€ 128,088 Total debts 2025: € 128,088 ▲ 34% vs 2024 (€ 95,511) Unfavourable step	▲ 34%
Cash	€ 220,015 Cash 2022: € 220,015 First fiscal year in the series	€ 43,051 Cash 2023: € 43,051 ▼ 80% vs 2022 (€ 220,015) Unfavourable step	€ 125,772 Cash 2024: € 125,772 ▲ 192% vs 2023 (€ 43,051) Favourable step	€ 101,886 Cash 2025: € 101,886 ▼ 19% vs 2024 (€ 125,772) Unfavourable step	▼ 19%
Retained profit	€ 438,837 Retained profit 2022: € 438,837 First fiscal year in the series	€ 99,763 Retained profit 2023: € 99,763 ▼ 77% vs 2022 (€ 438,837) Unfavourable step	€ 178,477 Retained profit 2024: € 178,477 ▲ 79% vs 2023 (€ 99,763) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 178,477) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 450,000 Dividend 2023: € 450,000 Unchanged (€ 0) Unchanged	€ 55,000 Dividend 2024: € 55,000 ▼ 88% vs 2023 (€ 450,000) Unchanged	€ 289,734 Dividend 2025: € 289,734 ▲ € 234,734 vs 2024 (€ 55,000) Unchanged	▲ € 234,734
Balance sheet total	€ 480,181 Balance sheet total 2022: € 480,181 First fiscal year in the series	€ 183,938 Balance sheet total 2023: € 183,938 ▼ 62% vs 2022 (€ 480,181) Unchanged	€ 292,588 Balance sheet total 2024: € 292,588 ▲ 59% vs 2023 (€ 183,938) Unchanged	€ 146,688 Balance sheet total 2025: € 146,688 ▼ 50% vs 2024 (€ 292,588) Unchanged	▼ 50%

Key figures of DR. SCHRAEPEN VÉRONIQUE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. SCHRAEPEN VÉRONIQUE?

What happened at DR. SCHRAEPEN VÉRONIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 31, 2026 New annual accounts for financial year 2025: profit of € 111,257 (▼ 17% vs 2024). Source: NBB ↗
Jul 6, 2018 New establishment in Lommel. KBO
2018 Véronique Schraepen became a director. NBB
Jul 6, 2018 Start of the company according to the CBE. KBO

In short

From € 105,642 profit in 2022 to € 111,257 profit in 2025.

Paid € 115,816 in corporate taxes since 2022.

Best year ever: 2024, with € 133,714 profit.

Paid out € 794,734 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. SCHRAEPEN VÉRONIQUE? We notify you, reason included.

Follow DR. SCHRAEPEN VÉRONIQUE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Véronique Schraepen

DR. SCHRAEPEN VÉRONIQUE

CONDITOR

Behind DR. SCHRAEPEN VÉRONIQUE is Véronique Schraepen. Véronique Schraepen is also behind CONDITOR.

See the full network in the app

Directors

According to the 2025 annual accounts

Véronique Schraepen

Director

Also active at: CONDITOR

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Lutlommel 69

3920 Lommel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

APOTHEEK DAMS MAARTEN

€ 659,039 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0699.692.771
VAT number: BE 0699.692.771
Registered office: Lutlommel 69, 3920 Lommel
Names & denominations: DR. SCHRAEPEN VÉRONIQUE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 July 2018
Peppol: Active · Active since 19 Sept 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗